Manufacturing
-
How MilliporeSigma Promotes Quality And Risk Reduction
10/20/2021
Learn how MilliporeSigma’s new facility was built with quality and risk reduction at the top of mind and its experts have the experience to support large-scale programs through commercialization.
-
The Impact Of Cell Therapy Manufacturing On Patient Access And Experience
4/15/2025
During this segment of Cell & Gene Live, expert panelists, Rohit Ingale, Head of Manufacturing & MSAT, Arcellx and David O’Donnell, Vice President, Head of Manufacturing, Vor Bio share why improvements in cell therapy manufacturing directly impact the patient experience.
-
Thermo Fisher Scientific Suzhou, China Manufacturing Site Capabilities
11/2/2018
Watch this video to learn more about this manufacturing site capabilities, quality management systems, PPI implementation, product expansion, assurance of supply and lead times.
-
CaptureSelect Affinity Chromatography
11/4/2025
30-second video sharing a visualization of our CaptureSelect affinity chromatography capability. The target protein binds with VHH molecules immobilized on the chromatography beads, non-target proteins are removed, and the eluted fraction contains a high yield of purified target protein.
-
How Automation Drives Down Cell Therapy Manufacturing Costs
2/26/2021
In this webinar segment, Dr. Mark Gilbert, Thomas Lequertier, and Luděk Sojka discussed how automation drives down manufacturing costs and the long road ahead to achieve continuous improvement.
-
Perfusion: Hardware Needs
6/16/2025
In this video, we will discuss cell retention mechanisms, pumps, and intensification challenges in the perfusion process.
-
Key Functions Of The ÄKTA Oligosynt Synthesizer
2/16/2023
Discover a compact, fully automated oligonucleotide synthesizer for robust, scalable process development. Learn how it can help establish a robust and reproducible oligo synthesis process.
-
Emerging Manufacturing Technologies For Cell Therapies | Audience Q&A
4/15/2025
Cell & Gene Live’s Audience Q&A always draws valuable questions in real time from our audience. Rohit Ingale, Head of Manufacturing & MSAT, Arcellx and David O’Donnell, Vice President, Head of Manufacturing, Vor Bio provide detailed responses to audience questions that addressed the importance of vein-to-vein time for non-cancer indications, such as autoimmune diseases.
-
Single-Use Manifolds For Operational Efficiency
2/23/2023
Learn how single-use manifolds can optimize your biomanufacturing processes, reducing time, space, and resources while increasing flexibility, product quality, and scalability.
-
Detecting Mycoplasma Contamination In Your Cell Culture
1/13/2023
Learn about Droplet Digital PCR, the mycoplasma detection kit workflow, how it can provide higher sensitivity, quantitative readout reports and more.